Pheiron
The AI engine Fit Assessment
BetaPheiron leverages machine learning to discover patterns and develop targeted therapeutics, while also focusing on biomarker identification for personalized medicine.
Blurb
Pheiron offers a data-driven platform for health management, enhancing drug development with AI and causal insights.
HQ Location
Berlin (Germany)
Founded
2023
Employees
1 - 10
Total funding raised
$4.22M
Funding Status
Venture - Series Unknown, $4.22M, June 20, 2025
Subspaces
- Biomarker Identification
Pheiron is an AI research lab working towards a future of deterministic drug development.
We are solving the hardest problem in drug development: anticipating what biology will work in humans.
We are build causal foundation models of human biology to algorithmically underwrite biology risk, identify next-generation opportunities and pick winning mechanisms.